Insiders · SQZ

David First

Officer at SQZ Biotechnologies Co (SQZ)

David First has filed 3 insider reports with the SEC since February 2021, as officer at SQZ Biotechnologies Co (SQZ). The latest filing, on January 26, 2023, reports grant or award at SQZ Biotechnologies Co (SQZ).

Filings
3
Companies
1
Bought on market
None
Sold on market
None

Companies where David First is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
SQZ Biotechnologies Co logo
SQZ
SQZ Biotechnologies Co
OfficerJan 26, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare David First with

Questions about David First

What is David First's role at SQZ Biotechnologies Co?
David First reports to the SEC as officer at SQZ Biotechnologies Co (SQZ), according to the latest filing on January 26, 2023.
Has David First bought or sold stock recently?
No open-market purchases or sales by David First are on file. The filings report grant or award.
How do I get alerts when David First files?
Follow David First on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David First (SEC CIK 0001767296). Totals count each trade once, skipping amendments whose original is on file, from Feb 25, 2021 on. View on SEC EDGAR · Get this as JSON